ClinicalTrials.Veeva

Menu

The Combination of PECS II Block and Parasternal Block for Radical Mastectomy

S

San Salvatore Hospital of L'Aquila

Status

Completed

Conditions

Breast Cancer

Treatments

Procedure: PECS II and parasternal block
Drug: Levobupivacaine

Study type

Interventional

Funder types

Other

Identifiers

NCT03754816
0180910/16

Details and patient eligibility

About

The combination of PECS II and parasternal Block provides analgesia after radical mastectomy

Full description

The cambionation of PECS II block and parasternal block

Enrollment

65 patients

Sex

Female

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ASA status patients:1,2 and 3
  • patients undergoing to radical mastectomy with axillary dissection and breast-implant reconstruction

Exclusion criteria

  • patients with allergy to local anesthetics
  • ASA status patients: 4
  • breast anatomy abnormalities
  • neurological diseases
  • septic conditions
  • coagulopathies
  • drug abuse history

Trial design

Primary purpose

Prevention

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

65 participants in 1 patient group

Experimental group
Experimental group
Description:
The combination of PECS II and parasternal block performed by injecting Levobupivacaine 0.375% 40 ml, injected between minor and major pectoralis muscles, between minor and serratus muscles and between major and intercostal muscles
Treatment:
Drug: Levobupivacaine
Procedure: PECS II and parasternal block

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems